Literature DB >> 9596248

Circadian variation in the timing of stroke onset: a meta-analysis.

W J Elliott1.   

Abstract

BACKGROUND AND
PURPOSE: Acute myocardial infarction and sudden death display a circadian rhythm, with a higher risk between 6 AM and noon. Some reports suggest that stroke does not follow such a circadian variation and that hemorrhagic stroke occurs more often during the evening.
METHODS: A meta-analysis of 31 publications reporting the circadian timing of 11,816 strokes was performed, subdividing (when possible) by the type of stroke, according to the time of onset of symptoms. When precise timing was not given, strokes were distributed evenly (that is, biasing toward the null hypothesis of lack of circadian variation).
RESULTS: All subtypes of strokes displayed a significant (P<0.001) circadian variation in time of onset, whether divided into 3-, 4-, or 6-hour time periods. There was a 49% increase (95% confidence interval, 44% to 55%) in stroke of all types between 6 AM and noon (compared with expectations if no circadian variation was present), which is a 79% (95% confidence interval, 72% to 87%) increase over the normalized risk of the other 18 hours of the day. There were 29% fewer strokes between midnight and 6 AM, a 35% decrease compared with the other 18 hours of the day. All three subtypes of stroke had a significantly higher risk between 6 AM and noon (55% for 8250 ischemic strokes; 34% for 1801 hemorrhagic strokes, and 50% for 405 transient ischemic attacks).
CONCLUSIONS: These data support the presence of a circadian pattern in the onset of stroke, with a significantly higher risk in the morning.

Entities:  

Mesh:

Year:  1998        PMID: 9596248     DOI: 10.1161/01.str.29.5.992

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  121 in total

Review 1.  Circadian system, sleep and endocrinology.

Authors:  Christopher J Morris; Daniel Aeschbach; Frank A J L Scheer
Journal:  Mol Cell Endocrinol       Date:  2011-09-10       Impact factor: 4.102

2.  Clinical pharmacology-physiology conference. A chrono-therapeutic approach to the treatment of hypertension.

Authors:  D T Lowenthal; J Estrada; R Cott
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

3.  Vulnerability to paroxysmal oscillations in delayed neural networks: a basis for nocturnal frontal lobe epilepsy?

Authors:  Austin Quan; Ivan Osorio; Toru Ohira; John Milton
Journal:  Chaos       Date:  2011-12       Impact factor: 3.642

Review 4.  Clocks not winding down: unravelling circadian networks.

Authors:  Eric E Zhang; Steve A Kay
Journal:  Nat Rev Mol Cell Biol       Date:  2010-11       Impact factor: 94.444

Review 5.  Death stroked by dusty air: more mysteries to be solved.

Authors:  J-C Chen
Journal:  Occup Environ Med       Date:  2007-01       Impact factor: 4.402

Review 6.  Twenty four hour ambulatory blood pressure monitoring: a new tool for determining cardiovascular prognosis.

Authors:  K Madin; P Iqbal
Journal:  Postgrad Med J       Date:  2006-09       Impact factor: 2.401

Review 7.  Circadian rhythm and cardiovascular disease.

Authors:  Elizabeth Shaw; Geoffrey H Tofler
Journal:  Curr Atheroscler Rep       Date:  2009-07       Impact factor: 5.113

8.  Smooth-muscle BMAL1 participates in blood pressure circadian rhythm regulation.

Authors:  Zhongwen Xie; Wen Su; Shu Liu; Guogang Zhao; Karyn Esser; Elizabeth A Schroder; Mellani Lefta; Harald M Stauss; Zhenheng Guo; Ming Cui Gong
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

9.  The effect of acetylsalicylic acid dosed at bedtime on the anti-aggregation effect in patients with coronary heart disease and arterial hypertension: A randomized, controlled trial.

Authors:  Beata Krasińska; Lech Paluszkiewicz; Ewa Miciak-Lawicka; Maciej Krasiński; Piotr Rzymski; Andrzej Tykarski; Zbigniew Krasiński
Journal:  Cardiol J       Date:  2018-11-28       Impact factor: 2.737

10.  Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR.

Authors:  J Sahoo; P N Murthy; S Biswal
Journal:  AAPS PharmSciTech       Date:  2009-01-15       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.